Polylactide Degradation Activates Immune Cells by Metabolic Reprogramming
Advanced Science · 2023-11 · 10 (31)
DOI: 10.1002/advs.202304632 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 22.09.2023. Verfasst von Chima V Maduka und 18 weiteren Autor:innen. Beteiligte Einrichtung: Comparative Medicine & Integrative Biology, Michigan State University, East Lansing, MI, 48824, USA. Hauptthemen laut MEDLINE: Polyesters, Inflammation. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: James and Kathleen Cornelius Endowment at Michigan State University.
Abstract (Originalsprache)
Polylactide (PLA) is the most widely utilized biopolymer in medicine. However, chronic inflammation and excessive fibrosis resulting from its degradation remain significant obstacles to extended clinical use. Immune cell activation has been correlated to the acidity of breakdown products, yet methods to neutralize the pH have not significantly reduced adverse responses. Using a bioenergetic model, delayed cellular changes were observed that are not apparent in the short‐term. Amorphous and semi‐crystalline PLA degradation products, including monomeric l ‐lactic acid, mechanistically remodel metabolism in cells leading to a reactive immune microenvironment characterized by elevated proinflammatory cytokines. Selective inhibition of metabolic reprogramming and altered bioenergetics both reduce these undesirable high cytokine levels and stimulate anti‐inflammatory signals. The results present a new biocompatibility paradigm by identifying metabolism as a target for immunomodulation to increase tolerance to biomaterials, ensuring safe clinical application of PLA‐based implants for soft‐ and hard‐tissue regeneration, and advancing nanomedicine and drug delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Comparative Medicine & Integrative Biology, Michigan State University, East Lansing, MI, 48824, USA.
- Department of Biomedical Engineering, Michigan State University, East Lansing, MI, 48824, USA.
- Institute for Quantitative Health Science & Engineering, Michigan State University, East Lansing, MI, 48824, USA.
- Department of Chemical Engineering & Materials Science, Michigan State University, East Lansing, MI, 48824, USA.
- School of Packaging, Michigan State University, East Lansing, MI, 48824, USA.
- Department of Orthopedic Surgery, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
ORCID-Profile: Chima V Maduka
Förderung
- James and Kathleen Cornelius Endowment at Michigan State University
Zitieren
APA
Maduka, C. V., Alhaj, M., Ural, E., Habeeb, O. M., Kuhnert, M. M., Smith, K., Makela, A. V., Pope, H., Chen, S., Hix, J. M., Mallett, C. L., Chung, S. J., Hakun, M., Tundo, A., Zinn, K. R., Hankenson, K. D., Goodman, S. B., Narayan, R., & Contag, C. H. (2023). Polylactide Degradation Activates Immune Cells by Metabolic Reprogramming. Advanced Science, 10(31). https://doi.org/10.1002/advs.202304632
Vancouver
Maduka CV, Alhaj M, Ural E, Habeeb OM, Kuhnert MM, Smith K, et al. Polylactide Degradation Activates Immune Cells by Metabolic Reprogramming. Advanced Science. 2023;10(31). doi:10.1002/advs.202304632
BibTeX
@article{Maduka2023,
author = {Maduka, Chima V and Alhaj, Mohammed and Ural, Evran and Habeeb, Oluwatosin M and Kuhnert, Maxwell M and Smith, Kylie and Makela, Ashley V and Pope, Hunter and Chen, Shoue and Hix, Jeremy M and Mallett, Christiane L and Chung, Seock-Jin and Hakun, Maxwell and Tundo, Anthony and Zinn, Kurt R and Hankenson, Kurt D and Goodman, Stuart B and Narayan, Ramani and Contag, Christopher H},
title = {Polylactide Degradation Activates Immune Cells by Metabolic Reprogramming},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {31},
doi = {10.1002/advs.202304632}
}
EUVIMED